Company Registry

Faknostics LLC
Profile last edited on: 2/18/2020

Focal Adhesion Kinase measurement and analysis for drug treatments
Year Founded
2014
First SBIR Year
2019
Latest SBIR Award
2021
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2914 East Minnezona
Phoenix, AZ 85016
   N/A
   N/A
   N/A
Multiple Locations:   
Congressional District:   09
County:   Maricopa

Public Profile

Spun out of the University of Arizona, FAKnostics LLC is a diagnostics company focused on the measurement of Focal Adhesion Kinase (FAK) in human tumor biopsies to determine the suitability of FAK-targeted cancer therapeutics. The company has developed an immunohistochemical kit which measures FAK experssion and helps patients decide which drug is best for them.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2021 2 NIH $964,131
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma

Key People / Management

  Jennifer Thompson -- Founder, CEO

  Timothy A Marlowe --

SBIR firms in the news

There are no news available.